by Ekrem Duman | Aug 10, 2026 | Pharma, Health & Cosmetics, Startup
⚡ TL;DRPierre Fabre is a uniquely structured French pharmaceutical and dermo-cosmetics group — with around €3.1 billion in revenue — that is majority-owned by a foundation, not shareholders or a family. Founded by a pharmacist in 1962, it pairs prescription medicines...
by Ekrem Duman | Aug 10, 2026 | Pharma, Health & Cosmetics, Startup
⚡ TL;DRIpsen is a French specialty biopharmaceutical company with €3.4 billion in 2024 sales, focused on three areas — oncology, rare diseases and neuroscience — and one of the world’s top-15 players in cancer medicines. Family-controlled by the Beaufour-Ipsen...
by Ekrem Duman | Aug 10, 2026 | Pharma, Health & Cosmetics, Startup
⚡ TL;DRbioMérieux is a world leader in in-vitro diagnostics — the tests that identify infections and contamination — with around €4 billion in 2024 revenue and 60 years of family stewardship under the Mérieux dynasty. Its business runs on a...
by Ekrem Duman | Aug 10, 2026 | Pharma, Health & Cosmetics, Startup
⚡ TL;DREssilorLuxottica is the world’s dominant eyewear company, a Franco-Italian giant with €26.5 billion in 2024 revenue that controls almost every step of the glasses business — from lenses and frames to brands, retail and even eye insurance. Formed by the...
by Ekrem Duman | Aug 10, 2026 | Pharma, Health & Cosmetics, Startup
⚡ TL;DRSanofi is France’s pharmaceutical champion, with around €41 billion in 2024 sales, transforming itself into a focused, science-driven biopharma company. Its blockbuster immunology drug Dupixent alone earns roughly €13 billion a year, its vaccines business...
